Young adults with hypertension may have increased cardiometabolic risks due to high uric acid levels.

New lipid-lowering therapy, administered subcutaneously just twice a year, offers significant and sustained reduction of LDL-C across a diverse group of patient populations.

If the agency follows the committee’s advice, it will issue a rule that would allow the compounds to be sold for any condition.

A 23-year analysis of hypertensive patients reveals differing cancer incidence patterns between two widely prescribed blood pressure medication classes, with variations across specific malignancies.

Most congenital hemangiomas on the skin are managed with standard therapies, but an expert specified lesions that are at risk for systemic complications to provide guidance for rapid intervention.

Why is it so hard to create a reliable biosensor? The concurrent stories of several researchers — decades in the making — may at last be reaching their final acts.

Androgen abuse in men is associated with modest changes in sleep-disordered breathing indices; however, sleep architecture remains largely preserved, and perceived sleep quality is unaffected.